Bingtao Hu Selected Research

MicroRNAs (MicroRNA)

12/2021

PAK5 promotes RNA helicase DDX5 sumoylation and miRNA-10b processing in a kinase-dependent manner in breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bingtao Hu Research Topics

Disease

3	Neoplasms (Cancer) 12/2021 - 08/2019
2	Breast Neoplasms (Breast Cancer) 12/2021 - 01/2021
1	Intervertebral Disc Displacement (Herniated Disc) 02/2024
1	Pain (Aches) 02/2024
1	Spinal Cord Diseases 01/2023
1	Surgical Blood Loss 01/2023
1	Neoplasm Metastasis (Metastasis) 12/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Kyphosis 08/2019
1	Compression Fractures (Compression Fracture) 05/2019
1	Lordosis 01/2019

Drug/Important Bio-Agent (IBA)

2	p21-Activated KinasesIBA 12/2021 - 01/2021
1	C-Reactive ProteinIBA 02/2024
1	MicroRNAs (MicroRNA)IBA 12/2021
1	Threonine (L-Threonine)FDA Link 12/2021
1	Phosphotransferases (Kinase)IBA 12/2021
1	RNA Helicases (RNA Helicase)IBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	TitaniumIBA 08/2019
1	Bone Cements (Bone Glue)IBA 05/2019

Therapy/Procedure

2	Diskectomy (Discectomy) 02/2024 - 01/2023
1	Operative Time 01/2023
1	Piezosurgery 01/2023
1	X-Ray Film 08/2019
1	Osteotomy 08/2019
1	Punctures 05/2019
1	Vertebroplasty 05/2019
1	Laminectomy 01/2019